BI 3820768
/ Boehringer Ingelheim
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
December 30, 2025
A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)
(clinicaltrials.gov)
- P1 | N=187 | Not yet recruiting | Sponsor: Boehringer Ingelheim
New P1 trial • Endometrial Cancer • Germ Cell Tumors • Oncology • Ovarian Cancer • Refractory Ovarian Cancer • Solid Tumor
1 to 1
Of
1
Go to page
1